• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Comprehensive study of pain and sleep in cancer chemotherapy

Research Project

Project/Area Number 17K08953
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Applied pharmacology
Research InstitutionKyushu University

Principal Investigator

Egashira Nobuaki  九州大学, 大学病院, 准教授 (80352269)

Project Period (FY) 2017-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords末梢神経障害 / 抗がん薬 / がん化学療法 / 痛み / 睡眠 / 軸索変性 / グルタミン酸 / 副作用 / 神経薬理学 / オキサリプラチン / 薬理学 / 神経障害
Outline of Final Research Achievements

In this study, we investigated the relationship between peripheral neuropathy and sleep in cancer chemotherapy, and searched for new preventive and therapeutic agents. As a result, it was not possible to find a clear relationship between peripheral neuropathy caused by anticancer drugs and sleep, but drugs such as ibudilast and kamishoyosan were prevented using PC12 cells and animal models of peripheral neuropathy. It was found to have an effect. Furthermore, it was confirmed that these drugs suppress axonal degeneration of the sciatic nerve. On the other hand, it was confirmed by studies using cancer cells and cancer-bearing animals that these drugs do not affect the antitumor effect of oxaliplatin. From the above research results, we found that ibudilast and kamishoyosan may be useful for anticancer drug-induced peripheral neuropathy.

Academic Significance and Societal Importance of the Research Achievements

オキサリプラチンなどの抗がん薬は、高頻度で末梢神経障害を引き起こし、患者の生活の質を著しく低下させるだけではなく、重篤例ではがん治療の継続が出来ず、臨床現場で切実な問題となっている。しかし、その発現機序は十分に明らかになっておらず、有効な予防・治療法も国内外において未だに確立されていない。本研究により、すでに医療用医薬品として使用されているイブジラストや加味逍遥散などの医薬品が軸索変性を抑制して抗がん薬誘発末梢神経障害に対して有用であることを見出したことは、大変意義のある成果であると考えられる。

Report

(6 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (29 results)

All 2021 2020 2019 2018 2017

All Journal Article (16 results) (of which Int'l Joint Research: 3 results,  Peer Reviewed: 16 results,  Open Access: 16 results) Presentation (13 results) (of which Int'l Joint Research: 3 results)

  • [Journal Article] Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats2021

    • Author(s)
      Nakamura Hiroko、Kawashiri Takehiro、Kobayashi Daisuke、Uchida Mayako、Egashira Nobuaki、Shimazoe Takao
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 44 Issue: 2 Pages: 271-274

    • DOI

      10.1248/bpb.b20-00620

    • NAID

      130007979607

    • ISSN
      0918-6158, 1347-5215
    • Year and Date
      2021-02-01
    • Related Report
      2021 Annual Research Report 2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy2021

    • Author(s)
      Yamamoto Shota、Egashira Nobuaki
    • Journal Title

      Frontiers in Pharmacology

      Volume: 11 Pages: 607780-607780

    • DOI

      10.3389/fphar.2020.607780

    • Related Report
      2021 Annual Research Report 2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy2021

    • Author(s)
      Yamamoto Shota、Egashira Nobuaki
    • Journal Title

      International Journal of Molecular Sciences

      Volume: 22 Issue: 2 Pages: 888-888

    • DOI

      10.3390/ijms22020888

    • Related Report
      2021 Annual Research Report 2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence2021

    • Author(s)
      Kawashiri Takehiro、Mine Keisuke、Kobayashi Daisuke、Inoue Mizuki、Ushio Soichiro、Uchida Mayako、Egashira Nobuaki、Shimazoe Takao
    • Journal Title

      International Journal of Molecular Sciences

      Volume: 22 Issue: 3 Pages: 1393-1393

    • DOI

      10.3390/ijms22031393

    • Related Report
      2021 Annual Research Report 2020 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats2021

    • Author(s)
      Egashira N, Goto Y, Takahashi R, Iba H, Yamamoto S, Watanabe T, Kubota K, Kawashiri T, Taniguchi C, Katsurabayashi S, Iwasaki K
    • Journal Title

      Journal of Pharmacological Sciences

      Volume: 147 Issue: 1 Pages: 114-117

    • DOI

      10.1016/j.jphs.2021.06.004

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Kamishoyosan potentiates pentobarbital-induced sleep in socially isolated, ovariectomized mice2021

    • Author(s)
      Egashira N, Goto Y, Iba H, Kawanaka R, Takahashi R, Taniguchi C, Watanabe T, Kubota K, Katsurabayashi S, Iwasaki K
    • Journal Title

      Journal of Ethnopharmacology

      Volume: 281 Pages: 114585-114585

    • DOI

      10.1016/j.jep.2021.114585

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Preclinical and clinical evidence of therapeutic agents for paclitaxel-induced peripheral neuropathy2021

    • Author(s)
      Kawashiri T, Inoue M, Mori K, Kobayashi D, Mine K, Ushio S, Kudamatsu H, Uchida M, Egashira N, Shimazoe T
    • Journal Title

      International Journal of Molecular Sciences

      Volume: 22 Issue: 16 Pages: 8733-8733

    • DOI

      10.3390/ijms22168733

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Lipid signaling in chemotherapy-induced peripheral neuropathy2021

    • Author(s)
      Yamamoto S, Egashira N
    • Journal Title

      Current Opinion in Toxicology

      Volume: 28 Pages: 1-6

    • DOI

      10.1016/j.cotox.2021.08.007

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Pathological mechanisms and preventive strategies of oxaliplatin-induced peripheral neuropathy2021

    • Author(s)
      Egashira N
    • Journal Title

      Frontiers in Pain Research

      Volume: 2 Pages: 804260-804260

    • DOI

      10.3389/fpain.2021.804260

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro2020

    • Author(s)
      Shigematsu Nao、Kawashiri Takehiro、Kobayashi Daisuke、Shimizu Shiori、Mine Keisuke、Hiromoto Shiori、Uchida Mayako、Egashira Nobuaki、Shimazoe Takao
    • Journal Title

      Scientific Reports

      Volume: 10 Issue: 1 Pages: 6734-6734

    • DOI

      10.1038/s41598-020-62738-w

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents2020

    • Author(s)
      Kawashiri Takehiro、Kobayashi Daisuke、Egashira Nobuaki、Tsuchiya Takashi、Shimazoe Takao
    • Journal Title

      Scientific Reports

      Volume: 10 Issue: 1 Pages: 12665-12665

    • DOI

      10.1038/s41598-020-69674-9

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Recent topics on the mechanisms of immunosuppressive therapy-related neurotoxicities2019

    • Author(s)
      Zhang W, Egashira N, Masuda S
    • Journal Title

      Int J Mol Sci

      Volume: 20 Issue: 13 Pages: 13-13

    • DOI

      10.3390/ijms20133210

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Pharmacological effects of yokukansan on behavioral and psychological symptoms of dementia2019

    • Author(s)
      Egashira N, Iwasaki K
    • Journal Title

      Trad Kampo Med

      Volume: 6 Pages: 115-125

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] New pharmacological effect of fulvestrant to prevent oxaliplatin-induced neurodegeneration and mechanical allodynia in rats2018

    • Author(s)
      Yamamoto S, Yamashita T, Ito M, Caaveiro JMM, Egashira N, Tozaki-Saitoh H, Tsuda M
    • Journal Title

      Int J Cancer

      Volume: - Issue: 8 Pages: 2107-2113

    • DOI

      10.1002/ijc.32043

    • Related Report
      2019 Research-status Report 2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Riluzole prevents oxaliplatin-induced cold allodynia via inhibition of overexpression of transient receptor potential melastatin 8 in rats2018

    • Author(s)
      Yamamoto S, Egashira N, Tsuda M, Masuda S
    • Journal Title

      J Pharmacol Sci

      Volume: 138 Issue: 3 Pages: 214-217

    • DOI

      10.1016/j.jphs.2018.10.006

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug2017

    • Author(s)
      Yamamoto Shota、Ushio Soichiro、Egashira Nobuaki、Kawashiri Takehiro、Mitsuyasu Shohei、Higuchi Hitomi、Ozawa Nana、Masuguchi Ken、Ono Yuko、Masuda Satohiro
    • Journal Title

      Scientific Reports

      Volume: 7 Issue: 1 Pages: 9661-9661

    • DOI

      10.1038/s41598-017-08891-1

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] がん化学療法誘発末梢神経障害の実際と対応策確立のための試み2021

    • Author(s)
      川尻 雄大、小林 大介、牛尾 聡一郎、江頭 伸昭、島添 隆雄
    • Organizer
      第14回日本緩和医療薬学会年会
    • Related Report
      2021 Annual Research Report
  • [Presentation] オキサリプラチン誘発機械的アロディニアに対する加味逍遥散の予防効果2020

    • Author(s)
      高橋亮太、江頭伸昭、後藤優、渡辺拓也、窪田香織、桂林秀太郎、岩崎克典
    • Organizer
      第37回和漢医薬学会学術大会
    • Related Report
      2020 Research-status Report
  • [Presentation] オキサリプラチン誘発末梢神経障害に対するシスチン・テアニン経口投与の有用性に関する基礎的検討2020

    • Author(s)
      川尻雄大、小林大介、江頭伸昭、島添隆雄
    • Organizer
      第30回日本医療薬学会年会
    • Related Report
      2020 Research-status Report
  • [Presentation] がん化学療法誘発末梢神経障害に対するDPP-4阻害薬アログリプチンの抑制作用に関する基礎的検討2020

    • Author(s)
      川尻雄大、重松奈央、清水栞、峯圭佑、廣本詩織、小林大介、江頭伸昭、島添隆雄
    • Organizer
      第41回日本臨床薬理学会学術総会
    • Related Report
      2020 Research-status Report
  • [Presentation] Role of MATE1 in the platinum-based chemotherapy against endometrial cancer2019

    • Author(s)
      Matsukane R, Katsube Y, Tajima S, Watanabe H, Egashira N, Masuda S
    • Organizer
      11th BioMedical Transporters Conference
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] オキサリプラチン誘発末梢神経障害に対する乳がん治療薬フルベストラントの保護効果2019

    • Author(s)
      山下智大、山本将大、伊藤麻結、カアベイロ ホセ、江頭伸昭、齊藤秀俊、津田誠
    • Organizer
      第13回日本緩和医療薬学会年会
    • Related Report
      2019 Research-status Report
  • [Presentation] 卵巣摘出マウスの隔離ストレスによるペントバルビタール誘発睡眠時間短縮に対する加味逍遥散の作用2019

    • Author(s)
      後藤優、江頭伸昭、射場日佳里、渡辺拓也、窪田香織、桂林秀太郎、岩崎克典
    • Organizer
      第36回和漢医薬学会学術大会
    • Related Report
      2019 Research-status Report
  • [Presentation] オキサリプラチンによる末梢神経障害の軽減・抑制を目指した基礎研究と今後の展望2019

    • Author(s)
      川尻雄大、小林大介、牛尾聡一郎、江頭伸昭、島添隆雄
    • Organizer
      第29回日本医療薬学会年会
    • Related Report
      2019 Research-status Report
  • [Presentation] 乳がん治療薬フルベストラントはオキサリプラチン誘発末梢神経障害を抑制する2019

    • Author(s)
      山本将大、山下智大、伊藤麻結、Caaveiro Jose M.M.、江頭伸昭、齊藤秀俊、津田誠
    • Organizer
      第92回日本薬理学会年会
    • Related Report
      2018 Research-status Report
  • [Presentation] Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia in rats2018

    • Author(s)
      Egashira N, Yamamoto S, Masuda S
    • Organizer
      WCP 2018, 18th World Congress on Basic and Clinical Pharmacology
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research
  • [Presentation] オキサリプラチン誘発末梢神経障害における脊髄グルタミン酸濃度の恒常性破綻と既承認薬リルゾールの保護効果2018

    • Author(s)
      山本将大、江頭伸昭、増田智先、津田 誠
    • Organizer
      日本薬学会第138年会
    • Related Report
      2017 Research-status Report
  • [Presentation] Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia in rats2018

    • Author(s)
      Nobuaki Egashira, Shota Yamamoto, Satohiro Masuda
    • Organizer
      WCP2018
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research
  • [Presentation] 医薬品の副作用対策研究2017

    • Author(s)
      江頭伸昭、増田智先
    • Organizer
      医療薬学フォーラム2017第25回クリニカルファーマシーシンポジウム
    • Related Report
      2017 Research-status Report

URL: 

Published: 2017-04-28   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi